Log In
Print this Print this

PINTA 745 (formerly AMG 745)

  Manage Alerts
Collapse Summary General Information
Company Atara Biotherapeutics Inc.
DescriptionRecombinant Fc-peptide fusion protein inhibiting myostatin (MSTN; GDF8)
Molecular Target Myostatin (MSTN) (GDF8)
Mechanism of ActionMyostatin (GDF-8) inhibitor
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today